Medical technology company Optomed is a leading manufacturer of handheld fundus cameras globally. By integrating our software solutions with our cameras, we enable eye screening for everyone – wherever they are.
Diabetic retinopathy
The number of people with diabetes has been growing rapidly around the world. One-third of them suffer from diabetic retinopathy, the most common cause of vision loss in working-age adults.
Diabetic retinopathy is treatable, if detected early. Due to the limited number of eye screening services, however, the majority of diabetics don’t have access to regular screenings.
50%+of diabetics skip |
95%of diabetics can reduce their risk of blindness |
38.4million Americans |
Our solution
Effective eye screening prevents diabetes-related blindness and reduces overall health care costs.
Our newest solution, Optomed Aurora AEYE, allows primary care physicians and their staff members to screen for and detect diabetic retinopathy instantly. The Optomed Aurora AEYE is the only FDA-cleared AI-enabled handheld fundus camera.
Contact Us